首页> 外文OA文献 >Improving animal welfare and reducing animal use for veterinary vaccine potency testing: state of the science and future directions
【2h】

Improving animal welfare and reducing animal use for veterinary vaccine potency testing: state of the science and future directions

机译:改善动物福利并减少动物对兽用疫苗效价测试的使用:科学现状和未来方向

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Veterinary vaccines contribute to improved human and animal health and welfare by preventing diseases and deaths caused by a wide range of infectious agents. However, testing necessary to ensure vaccine effectiveness and safety can involve large numbers of animals and significant pain and distress. NICEATM and ICCVAM convened an international workshop to review the state of the science of human and veterinary vaccine potency and safety testing methods and to identify opportunities to advance new and improved methods that can further reduce, refine, and replace animal use. This workshop report is the fourth in a series of six, and addresses methods and strategies for veterinary vaccine potency testing that can avoid or lessen pain and distress, improve animal welfare, and reduce animal use. Vaccine potency tests considered to have the highest priority for further reduction and refinement were those that require an infectious agent challenge test or an in vivo toxin neutralization test, those that require large numbers of animals, and those that require the use of infectious agents hazardous to laboratory workers and/or animals. Vaccines identified as high priorities for improved alternative test methods were rabies, Clostridium spp., Leptospira spp., foreign animal diseases (e.g., foot and mouth disease), and poultry and fish vaccines. The workshop recommended priority research, development, and validation activities to address critical knowledge and data gaps, including opportunities to apply new science and technology. Recommendations to support more humane animal use included development and use of humane endpoints for all challenge tests, development of serologic assays to replace challenge tests, and development of in vitro toxin neutralization tests to replace in vivo TNTs. Workshop participants recommended approaches to reduce the number of animals required for potency testing, and recommended enhanced international harmonization and cooperation, and closer collaborations between human and veterinary researchers to expedite progress in the development and application of alternative methods. Implementation of the workshop recommendations is expected to advance new methods for veterinary vaccine potency testing that will benefit animal welfare and reduce animal use while ensuring continued protection of human and animal health.
机译:兽医疫苗通过预防由多种传染源引起的疾病和死亡,有助于改善人类和动物的健康和福祉。但是,确保疫苗有效性和安全性所必需的测试可能会涉及大量动物,并且会带来极大的痛苦和困扰。 NICEATM和ICCVAM召集了一个国际研讨会,以审查人类和兽医疫苗效价和安全性测试方法的科学状况,并寻找机会推广可以进一步减少,改良和替代动物用途的新方法和改进方法。该研讨会报告是六个系列报告中的第四次,介绍了兽用疫苗效价测试的方法和策略,这些方法和策略可以避免或减轻疼痛和痛苦,改善动物福利,并减少动物使用。被认为是进一步减少和精炼最优先的疫苗效价测试是那些需要传染剂挑战试验或体内毒素中和试验的试验,那些需要大量动物的试验以及那些需要使用对人体有害的传染剂的试验。实验室工作人员和/或动物。被确定为改进替代测试方法的高度优先事项的疫苗是狂犬病,梭菌,钩端螺旋体,外来动物疾病(如口蹄疫)以及家禽和鱼疫苗。研讨会建议进行优先研究,开发和验证活动,以解决关键的知识和数据缺口,包括应用新科学和技术的机会。支持更多人道动物使用的建议包括开发和使用人道终点用于所有挑战试验,开发血清学检测方法以替代挑战试验,以及开发体外毒素中和试验以替代体内TNT。讲习班的参与者建议了减少效能测试所需动物数量的方法,并建议加强国际协调与合作,并建议人类与兽医研究人员之间进行更紧密的合作,以加快替代方法的开发和应用。预计研讨会建议的实施将促进兽用疫苗效力测试的新方法,这将有益于动物福利并减少动物使用,同时确保对人类和动物健康的持续保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号